Consist of drug substances and other components as dry-formulation ingredients to ensure chemical and physical stability of the presentation within final-use container Companion sterile diluent or diluent compartments may be provided to facilitate constitution to the desired final volume. lyophilized intended for final solution, solids intended for final solution, or dry solids that form viscous upon constitution